Proactive - Interviews for investors
hVIVO CEO on milestone Phase III whooping cough trial for ILiAD
hVIVO CEO Yamin Khan speaks about a significant Phase III human challenge trial for ILiAD’s whooping cough vaccine. This trial represents the largest contract in hVIVO's history and aims to accelerate the development of new treatments.